ThermoGenesis Holdings Inc. (THMO) Is A Stock You Should Watch


As of Friday close, ThermoGenesis Holdings Inc.’s (NASDAQ:THMO) stock was down -$0.95, moving down -15.83 percent to $5.05. The average number of shares traded per day over the past five days has been 12,818,239 shares. 4 times new highs have been achieved over the past 5 days, with a $2.79 gain in that time frame. In the last twenty days, the average volume was 3,224,605, while in the previous 50 days, it was 1,368,222.

Since last month, THMO stock rose 36.49%. Shares of the company fell to $2.11 on 03/14/23, the lowest level in the past month. A 52-week high of $40.49 was reached on 03/17/23 after having rallying from a 52-week low of $2.11. Since the beginning of this year, THMO’s stock price has risen by 57.81% or $1.85, and marked a new high 9 times. However, the stock has declined by -87.53% since its 52-week high.

From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio

The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.

Get our free report, "Top 5 AI Stocks to Buy for 2023".


Valuation Metrics

The stock’s beta is 2.59. Besides these, the trailing price-to-sales (P/S) ratio of 0.57, the price-to-book (PB) ratio of 31.56.

Financial Health

In the three months ended September 29, ThermoGenesis Holdings Inc.’s quick ratio stood at 0.60, while its current ratio was 1.00, showing that the company is not able to pay off its debt. On the profitability front, the trailing twelve-month gross margin is 29.30% percent. In the year ended September 29, operating margins totaled -58.80%. Based on annual data, THMO earned $3.49 million in gross profit and brought in $9.29 million in revenue.

According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. THMO’s revenue fell -49.06% to $3.03 million during the quarter, while net income inched up to $2.12 million. While analysts expected ThermoGenesis Holdings Inc. to report -$1.35 quarterly earnings, the actual figure was -$4.5 per share, beating the consensus estimate by -233.30%. During the quarter, the company generated -$0.82 million in EBITDA. The liabilities of ThermoGenesis Holdings Inc. were 15.83 million at the end of its most recent quarter ended September 29, and its total debt was $10.36 million. The value of shareholders’ equity is $1.02 million.

Technical Picture

This quick technical analysis looks at ThermoGenesis Holdings Inc.’s (THMO) price momentum. With a historical volatility rate of 411.82%, the RSI 9-day stood at 67.57% on 17 March.

With respect to its five-day moving average, the current ThermoGenesis Holdings Inc. price is up by +123.45% percent or $2.79. At present, THMO shares trade +71.19% above its 20-day simple moving average and -56.08% percent below its 100-day simple moving average. However, the stock is currently trading approximately +48.53% above its SMA50 and -69.42% below its SMA200.

Stochastic coefficient K was 74.91% and Stochastic coefficient D was 51.03%, while ATR was 0.89. Given the Stochastic reading of 64.47% for the 14-day period, the RSI (14) reading has been calculated as 64.13%. As of today, the MACD Oscillator reading stands at 1.78, while the 14-day reading stands at 1.88.

Analyst Ratings

H.C. Wainwright launched its rating on ThermoGenesis Holdings Inc. (NASDAQ: THMO) to a Buy in a note to investors on May 23, 2018. ThermoGenesis Holdings Inc. (THMO) has been rated Buy by analysts. According to 0 brokerage firms, THMO is a sell, and 0 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate ThermoGenesis Holdings Inc. stock as buy, with 1 recommending it as overweight.


Please enter your comment!
Please enter your name here